GLG News by Mr. Bruce Goldberg, Pharmacist
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
Rx Savings with Generic vs Branded Medications
March 28, 2011
Buying Brand-Name Drugs Over Generics Raises Medicaid Costs | www.bloomberg.com
With dollar shortfalls for Rx benefits, controlling drug costs is imperative. By utilizing a strict formulary of covered products, along with clear, real time messaging to the pharmacies, the generic fill rate (GFR) will rise. With a higher GFR, savings is attained.
-
Lupin's opportunity to drop the Lotrel margin!
February 15, 2010
Lupin gets US FDA approval for hypertension capsules | www.pharmabiz.com
The approval of Lupin's generic Lotrel line will create one more player in a field that is currently not very crowded. Yet, don't expect the other players to not react! Generic Lotrel is currently priced relatively high compared to other multi-source hypertensive products.
-
Cetirizine OTC liquid. A day late and a dollar short.
February 8, 2010
Aurobindo Pharma receives final approval for Cetirizine Hydrochloride Solution (OTC) | www.pipelinereview.com
Why the delay? Teva, Taro, and Perrigo all have strong footholds in this market. Rx and OTC competition remains strong, thus what would allow a new player to grow quickly outside of eroding the price market?
-
Reverse Payments for PHRMA smell fishy
May 15, 2008
US trade agency wants to end deals delaying generics | www.reuters.com
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families. My grandpa used to call this stuff by another term....."shmearing".
Page : 11 to 4 of 4
- Subscribe to Updates
-
Leading institutions connect with Bruce Goldberg through GLG
Most Popular Healthcare News
-
February 7, 2012
-
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
-
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
-
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
-
Medtech M&A activity accelerates in 2011
November 30, 2011
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.